Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Beats on EPS, Stock Up 0.43%

Vertex Pharmaceuticals reported better-than-expected earnings per share, which led to a slight increase in the stock price by 0.43%. However, there was no revenue figure provided, and no guidance was offered for future performance. The strong EPS surprise may indicate positive momentum in the company's operations.